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Abstract
Background: Factors affecting the success of short tandem repeat (STR) amplification of poorly preserved samples
are generally known, but as of yet, they have seldom been systematically assessed. Using two different maximum
likelihood-based methods, the relative importance of DNA quantity, degradation and inhibition in STR genotyping
was studied with DNA extracts from a set of old bone samples. First, the effects of different factors related to PCR
amplification were estimated with a generalized linear mixed model. Second, error rates of allelic drop-out and
drop-in were estimated on the basis of the frequency and nature of mismatches between replicates.
Results: In autosomal STR analyses, the most important factor was the DNA quantity, followed by the degradation,
whereas in Y-chromosomal STR analysis, the most important factor was the degradation. Inhibition was a minor
concern in STR analyses of poorly preserved bones.
Conclusions: The success of PCR amplification depends largely on the template DNA quality (amount and
degradation), but these problems can be partly compensated for by different primer design and amplification
chemistry. Consequently, the relative roles of the compromising factors differ according to the kit used.
Background
Geneticists working in the fields of forensics and ancient
DNA are frequently forced to attempt the recovery of
amplifiable DNA from quantificatively and qualitatively
suboptimal material. Successful PCR amplification from
old and/or otherwise poorly preserved specimens is
challenging, because the success depends on several fac-
tors, such as the amount of recoverable DNA, the level
of DNA damage and the inhibiting agents present. In
addition, the chemistry and methods used for DNA
extraction and amplification may have a strong effect on
the amplification success. The role of these different
attributes has been recognized [1-3], but their relative
significance has rarely been assessed.
In this study, the roles of the compromising factors
were evaluated by investigating the effect on PCR suc-
cess of both amount and quality of the template DNA,
and of the amplification kit used. To accomplish this
goal we estimated the relative roles of various factors
simultaneously using univariate variance analysis. Owing
to the stochastic effects associated with the analyses of
samples of low DNA quantity, evaluation of the com-
promising factors is important in increasing the reliabil-
ity and efficiency of the analysis [4-6]. Recently, there
has been a dramatic increase in the number attempts of
recovering DNA from poor quality samples, such as
archaeological and forensic bones [6-8].
Materials and methods
DNA extracts of poorly preserved bone samples were
genotyped with three different commercial short tandem
repeat (STR) kits. The PCR success, measured by the
relative fluorescence unit (RFU) values, was evaluated in
relation to various attributes: amount of DNA present
in the extracts, inhibition (as determined by the quanti-
fication assay), amplicon length and STR kit used. This
allowed correlation of the effects of DNA quantity, inhi-
bitors, degradation and PCR chemistry (for example, pri-
mers) to PCR success. The interdependence of PCR
success and size of the amplified PCR product (allele
size) was used to assess degradation of the template
DNA. In addition, the number of stochastic genotyping
errors (allelic drop-out and drop-in rates) was estimated.
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inhibition
Human bones around 70 years old were used as the
material for the study. These bones had been recovered
from 14 different locations (each with several excavation
sites) in an area of about 100 × 200 km for identifica-
tion of missing Finnish World War II soldiers [9]. These
human remains were recovered from different depths
and soil types in southern boreal forests. The bones had
been subjected to various taphonomic factors, which
had resulted in differing levels of physical degradation.
DNA was extracted from femoral bones of 45 indivi-
duals. Before DNA extraction, the bone surfaces were
cleansed mechanically using sterile toothbrushes, then
rinsed once with sterile water and once with sodium
hypochlorite solution containing 0.08% active chlorine.
Finally, the bones were rinsed with 70% ethanol and
dried at room temperature for a minimum of 24 hours.
Using a dental hand drill (Faro, Milan, Italy) the bone
surface was stripped, and the revealed inner compact
bone tissue pulverized. Approximately 0.5 g of bone
powder was incubated in lysis buffer at 56°C overnight
according to a previously described protocol [10]. DNA
was extracted from the lysates by the standard phenol-
chloroform-isoamyl alcohol method [11] on 50 ml
phase-lock gel columns (5 Prime, Hamburg, Germany)
and concentrated by centrifugation, reducing the total
volume to 150 to 200 μl, on 50 ml columns (Amicon
Ultra 30; Millipore, Billerica, MA USA). Finally, the
extracts were purified (QIAQuick PCR Purification Kit;
Qiagen, Hilden, Germany).
Extractions were performed with strict precautions
including protective clothing, with equipment and sur-
faces treated with chlorine and/or irradiated with UV.
Only a small number (≤ 6) of bone samples were
extracted at one time, and blank controls were used to
detect possible contamination. Furthermore, the geno-
typing results were compared against the lab personnel
profiles to check for authenticity.
Nuclear DNA and inhibition were quantified on a real-
time PCR system (ABI7500; Applied Biosystems, Foster
City, CA USA) using a quantification kit (Quantifiler™Hu-
man DNA Quantification Kit; Applied Biosystems)
according to the manufacturer’s recommendations. Quan-
tification of the mitochondrial (mt)DNA was performed
as described previously [12], with two amplicons (102
and 143 bp) allowing crude estimation of degradation.
Genotyping and assessment of PCR chemistry
Y-chromosomal and autosomal STR loci were amplified
from two parallel 1 μl aliquots of extracted DNA sam-
ples using three different amplifier kits (AmpFlSTR® Yfi-
ler™(YF), AmpFlSTR® Minifiler™(MF) and AmpFlSTR®
Identifiler™(IF); all Applied Biosystems). YF amplifies 17
Y-chromosomal STRs with allele sizes ranging from 103
to 291 bp. MF and IF amplify a sex-specific amelogenin
locus (107 and 113 bp alleles) together with eight and
15 autosomal loci with allele sizes ranging from 96 to
216 bp and 125 to 315 bp, respectively. PCR was per-
formed in a thermal cycler (Tetrad PTC-225; MJ
Research, Waltham, MA USA) according to the manu-
facturer’s instructions, apart from the number of PCR
cycles (32 for Y-chromosome STRs, 30 for autosomal
S T R s )a n dt h er e a c t i o nv o l u m e( 1 2 . 5μl). Positive (male
DNA, catalogue number 9947A or 9948; Promega
Corp., Sunnyvale, CA USA) and negative (water filtered
through Milli-Q filters; Millipore) controls were
included in all analyses. The PCR products were ana-
lyzed with capillary electrophoresis (ABI Prism® 310;
Applied Biosystems) using 10 second and 15.0 kV
injection.
The genotyping results were analyzed (GeneMapper-
ID™V.3.2; Applied Biosystems), using both 30 and 100
RFU as the limit of detection in the allele peak scoring.
Hereafter, the combination of the kit and the limit of
detection are abbreviated as IF30, IF100, MF30, MF100,
YF30 and YF100. For the peak height imbalance, a
relaxed criterion of smaller peak being ≥ 30% of the lar-
ger peak height was adopted. For each peak, the RFU
value was used as an indicator of amplification success
in the subsequent data analyses.
Evaluation of STR amplification in relation to
compromising factors
A maximum likelihood (ML) based generalized linear
mixed model (GLMM), using the PROC MIXED proce-
dure and the COVTEST statement implemented in SAS
software V.9.1 (SAS Institute Inc., Cary, NC USA) was
used to estimate the effects of allele size, quantity of
DNA, inhibition, and amplification kit (modelled as
fixed effects) on the PCR success (RFU values), while
accounting for any covariation inherent to the structure
of the data; that is, individual sample, replicate (nested
in individual), locus and allele (first or second allele
nested in a locus), modelled as random effects.
The model was run separately for a nSTR dataset of
each studied kit with both limits of detection (30 and
100 RFU). For assessing the effect of the kit, datasets
consisting of nine common loci in IF and MF were
pooled and analyzed together with both limits of
detection.
Allelic drop-out and drop-in rates for the autosomal
data were assessed as an additional indicator of the PCR
amplification success. The frequencies of these stochas-
tic genotyping errors were estimated with a method
implemented in the software Pedant V.1.0 [13]. The
95% confidence intervals for these estimates were deter-
mined by 10,000 randomization steps. The method is
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rates from the frequency and nature of mismatches
between two replicate amplifications. As a given para-
meter value for each locus, the expected heterozygosity
(He), ranging from 0.59 to 0.87, was estimated from a
random sample of 200 Finnish people.
Results and Discussion
The main picture emerging from this study is that the
two most important factors affecting PCR success are
DNA quantity and degradation. Inhibition was found to
be relatively insignificant. All the GLMM analyses were
made separately for limits of detection set to 30 and 100
RFU, but both gave similar results (not shown). Conse-
quently, the discussion is mainly based on the results
with the limit of detection of 100 RFU.
Overall, the GLMM analysis showed that PCR success
was significantly affected by DNA quantity, allele size
and amplification kit (see Additional file 1). DNA quan-
tity had a larger effect on the MF amplification kit, and
inhibition was also found to affect only the MF kit (see
Additional file 1). Variance in RFU values was explained
in part by sample (average across kits and range: 11%
(range 0.5 to 21%), 0.0001 ≤ P ≤ 0.384), replicate (3.5%
(1.0 to 5.0%), 0.001 ≤ P ≤ 0.070), locus (21% (16 to
28%), 0.004 ≤ P ≤ 0.028), but mostly by residual var-
iance, (66.5% (58 to 79%), P < 0.0001). The residual var-
iance is the variance in RFU values not accounted by
the factors (that is, fixed and random) included in the
model.
The validity of the data was also assessed by estimat-
ing the drop-in rates in autosomal STR analyses. The
point estimate of drop-ins was 0.01 (95% CI, 0.00 - 0.02)
in all autosomal STR analyses, which was close to the
estimated contamination level reported previously of
0.008 ± 0.002% [14] and 1.36% [15], supporting the
validity of the analysis results, even with the limit of
detection set as low as 30 RFU.
DNA quantity
T h eq u a n t i t yo fn u c l e a rD N Ap e rs a m p l ev a r i e df r o m
‘undetectable’ (five samples) to 1.5 ng/μl, with an aver-
age of 0.47 ng/μl (95% CI, 0.46 - 0.48). According to the
manufacturer’s sensitivity studies, the nuclear DNA
quantification assay can detect DNA concentrations of
0.016 ng/μl. The DNA quantity was the most important
factor in PCR success for autosomal STR data, and the
second most important factor in the Y-chromosomal
data (see Additional file 1, F values).
For each amplification reaction, 1 μl of DNA extract
was used, corresponding to an estimated quantity of 0
to 1.5 ng nuclear DNA per reaction. Reproducibility of
the PCR amplifications was comparable with the tem-
plate concentration; however, the samples with the
lowest detected DNA concentration (0.04 ng/μl) also
yielded some reproducible amplification products. Four
of the five samples with ‘undetectable’ nuclear DNA
concentration also exhibited 100% inhibition.
The quantities of mtDNA did not appear to have a
s i g n i f i c a n te f f e c to nt h es u ccess of STR amplification
(that is, RFU values) (see Additional file 1). This is in
line with previous studies, such as that of Schwarz et al.
[16], which showed highly variable ratio of mtDNA to
nuclear DNA in mammoth (Mammuthus primigenius)
DNA samples. In the casework, successful DNA
sequences in the mitochondrial HVR1 (nucleotide posi-
tions 16024 - 16385) and HVR2 (72 - 340) regions were
obtained from 40 of the samples. For the remaining five
samples, the sequences were obtained after additional
laboratory work.
Degradation
Rather than DNA quantity, allele size was the most
important contributor to the RFU value in the Y-chro-
mosomal STR data. The effect of allele size was 1.4
times the effect of the quantity of nuclear DNA (see
Additional file 1, F values). In autosomal STRs, the cor-
responding effect was 0.7 in IF analysis and 0.1 times in
MF analysis.
The mtDNA quantification results also yielded infor-
mation about degradation. The quantities determined
with the 102 bp amplicon were around 3.8 times greater
than the quantities with the 143 bp amplicon, implicat-
ing degradation of (mt)DNA (Figure 1). It seems that
mtDNA and nuclear DNA degrade at varying relative
rates under different conditions, as has been reported
previously [16].
The effect of degradation on autosomal STRs was
assessed by an allelic drop-out study. Average estimates
of drop-out frequencies were 0.07 (95% CI, 0.04 - 0.10)
for MF loci and 0.20 (95% CI, 0.13 - 0.27) for IF loci.
In the shortest IF loci (average allele sizes ranging
from 125 to 216 bp) the average drop-out frequency
0.11 (95% CI, 0.07 - 0.15) was similar to that of MF
loci, indicating that the effect stems largely from the
template DNA degradation (Figure 2). The connection
between decreased amplifiability of longer amplicons
and degradation of DNA is not a new finding [17-19],
and it is intuitively evident. However, care is needed
when interpreting degradation from the amplification
differences of independent loci, because each locus is
amplified with a different set of primers. High interlo-
cus variance (16 to 28%) in RFU values can be seen as
implying differences in amplification chemistry. Never-
theless, the results of quantification of mtDNA at the
same locus with amplicons of different lengths as well
as the estimates of the drop-out rates support the
notion of degradation.
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The intercept is forced to origin. R
2 is the coefficient of determination of linear regression.
Figure 2 Dropout rates in autosomal short tandem repeat (STR) analyses. IF (black circles) and MF (white circles), plotted against the
average allele length of each locus. Limit of detection was 100 relative fluorescence units (RFU).
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for routine work, but are here explained largely by the
unmodified experimental setup, in which DNA quantity
was taken as an independent variable. The PCR amplifi-
cations were also performed without adjusting template
concentrations or successive optimization of conditions.
When considering the effect of amplicon length on
PCR success, the effect of buffer and/or enzyme differ-
ences between different kits cannot be completely
ignored. However, similar drop-out frequencies observed
in shorter amplicons of different kits support the conclu-
sion that instead of the differences in the amplification
chemistries, the degradation (amplicon length), is deci-
sive. However, similar drop-out frequencies observed in
shorter amplicons with different kits support the conclu-
sion that it is the degradation (the amplicon length)
rather than the differences in the amplification chemis-
tries that is decisive. In regression analysis of drop-out
rates and amplicon sizes, the only significant regression
was observed in IF data (see Additional file 2). This is
probably a result of the large size range of the amplicons
in the IF data contributing to the increased differences
within the dataset.
The ML estimates for drop-out and drop-in rates are
only obtainable for diploid data. At the Y-chromosomal
loci, 67% of the samples yielded an amplification pro-
duct in both replicates, 13% of the samples yielded a full
profile, and in 46% of the samples, at least 13 out of 17
loci amplified.
Inhibition
Inhibition estimates varied from 0% (7 samples) to 100%
(6 samples), with an average of 15% and median of 3%.
The amount of inhibition had a bimodal distribution
around 0 to 25% and 100%.
In the MF data, inhibition was a significant factor, the
effect of which was around three times that of the allele
size (see Additional file 1, F values). This does not
necessarily mean poor performance in absolute terms.
The shorter amplicons are less sensitive to degradation,
which is likely to increase the relative importance of
inhibition. When the relaxed limit of detection of 30
was applied, the effect increased to around nine times
the effect of the allele size (not shown). By contrast,
inhibition had little effect on YF data (see Additional
f i l e1 ) .E v e ni nt h es a m p l e sw i t ha ne s t i m a t e d1 0 0 %
inhibition, on average of 8.0 loci could be amplified, and
one of the samples yielded 15 scorable loci. No signifi-
cant regression between the estimated inhibition level
and amount of amplified loci was found with any ampli-
fication method. However, it is worth noting that the
experiment setup was not designed to answer this ques-
tion specifically.
Amplification kit
Autosomal STR chemistry (IF or MF) had a significant
effect on PCR success. The effect was about 0.5 times the
effect of DNA quantity and 2.1 times the effect of inhibi-
tion (see Additional file 1, F values). When the relaxed
limit of detection (30 RFU) was used, the effect of kit
rose to the level of DNA quantity and up to 4.9 times
the effect of inhibition (not shown). Here, the relative
increase in the kit effect resulted from a stronger bias to
shorter amplicons (that is, MF data) with the relaxed
limit of detection of 30 RFU. In the different kits, differ-
ent primers are used to amplify the same loci, and in
poorly preserved samples shorter amplicons surpass the
longer ones in amplification efficiency. This has also
been the aim in the introduction of mini-STR kits.
The differences between kits are illustrated in Figure 3,
Figure 3 Least squares means of relative fluorescence unit (RFU) values for the nine loci common for both AmpFlSTR® Minifiler™(MF)
and AmpFlSTR® Identifiler™(IF) kits. Bars represent 95% confidence intervals in both limits of detection (30 and 100 RFU)
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with 95% CI.
Conclusions
The quantity of nuclear DNA quantity and its degrada-
tion (allele size) were the most significant factors affect-
ing PCR success from poorly preserved bones.
Compared with the effect of DNA amount and degrada-
tion, inhibition is a minor concern, but its relative role
increases when shorter amplicons are amplified.
This study highlights the requirement for efficient
D N Ae x t r a c t i o n .An u m b e ro fd i f f e r e n tm e t h o d sh a v e
been developed for DNA extraction, with varying perfor-
mances from different types of starting material
[17,20,21]. The extraction method in the present study
was fixed, and was based on the protocol validated in
our laboratory. DNA analyses from suboptimal material
require laboratory-specific method adjustment and vali-
dation for each sample type. The most significant pro-
blems, such as degradation, are template-dependent and
cannot be completely circumvented. Nevertheless, by
improving the PCR (for example, by short amplicons,
with modifications of the buffer system or enzymes
used) these problems can be partially overcome. This is
supported by the current results, showing that the exist-
ing PCR amplification chemistries were affected differ-
ently by the compromising factors.
Additional material
Additional file 1: Fixed effect (DNA Quantity, inhibition, allele size
and kit) results from the GLMM analyses in different analyses with
limit of detection being 100 relative fluorescence units (RFU). Effect
size of each factor is given as F value, which denotes the difference
between the overall mean of the RFU values and the mean RFU for each
factor. Significant P values are in bold. DNAQ = nuclear DNA quantity,
DNAQ_S and DNA_L = mtDNA quantity (102 bp and 143 bp fragments
respectively).
Additional file 2: Regression analysis of drop-out rates in different
autosomal short tandem repeat (STR) analyses analysed with the
software Pedant V.1.0. The effect sizes are given as F values. Significant
P values are in bold. For abbreviations, see text.
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